USANA Health Sciences (NYSE:USNA) Shares Gap Up on Earnings Beat

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) gapped up before the market opened on Wednesday following a better than expected earnings announcement. The stock had previously closed at $31.53, but opened at $37.00. USANA Health Sciences shares last traded at $34.86, with a volume of 50,255 shares trading hands.

The company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.20. The business had revenue of $235.85 million for the quarter, compared to analysts' expectations of $225.20 million. USANA Health Sciences had a net margin of 3.79% and a return on equity of 9.48%.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded USANA Health Sciences from a "hold" rating to a "buy" rating in a research note on Thursday, May 22nd.

Insider Transactions at USANA Health Sciences

In related news, COO Walter Noot sold 6,291 shares of the business's stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total transaction of $190,554.39. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO G Doug Iiekking sold 4,548 shares of the business's stock in a transaction that occurred on Friday, May 9th. The shares were sold at an average price of $29.61, for a total value of $134,666.28. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 12,013 shares of company stock valued at $360,149. Corporate insiders own 0.63% of the company's stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in USNA. US Bancorp DE grew its position in USANA Health Sciences by 13.1% in the 1st quarter. US Bancorp DE now owns 4,611 shares of the company's stock valued at $124,000 after acquiring an additional 535 shares during the last quarter. Exchange Traded Concepts LLC grew its position in shares of USANA Health Sciences by 7.1% during the 1st quarter. Exchange Traded Concepts LLC now owns 9,184 shares of the company's stock worth $248,000 after buying an additional 606 shares in the last quarter. PNC Financial Services Group Inc. grew its position in shares of USANA Health Sciences by 339.6% during the 1st quarter. PNC Financial Services Group Inc. now owns 998 shares of the company's stock worth $27,000 after buying an additional 771 shares in the last quarter. Martingale Asset Management L P grew its position in shares of USANA Health Sciences by 5.4% during the 1st quarter. Martingale Asset Management L P now owns 17,542 shares of the company's stock worth $473,000 after buying an additional 900 shares in the last quarter. Finally, Versant Capital Management Inc grew its position in shares of USANA Health Sciences by 542.5% during the 1st quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock worth $31,000 after buying an additional 971 shares in the last quarter. 54.25% of the stock is owned by hedge funds and other institutional investors.

USANA Health Sciences Trading Down 0.4%

The business has a 50-day moving average price of $30.89 and a 200-day moving average price of $30.09. The firm has a market cap of $595.28 million, a P/E ratio of 17.76, a P/E/G ratio of 1.02 and a beta of 0.64.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.